Medical wearable devices are used by no one? The crux is here! !

Release date: 2015-11-25

Medical wearable device development syndrome analysis
A wearable device is an electronic or intelligent computing device that is worn or implanted on the surface or inside of a human body. The wearable device is an electronic or intelligent computing device that is worn or implanted on the surface or inside of the human body, and belongs to the Internet of Things. At present, domestic wearable devices are mainly used in the fields of chronic diseases, old-age care, women and children, and smart sportswear, and are classified into sports health and medical wearable devices. Domestic wearable device manufacturers generally adopt two business strategies, one is self-developed hardware and application App, which leads sales, promotion and post-data mining; the other is self-developed hardware, which is promoted by WeChat, Apple Health Kit and other health data platforms. , get late income.
As the core application form of the Internet of Things, domestic wearable devices belong to the blue ocean of the market, but the Chinese manufacturers are facing two major problems on the road ahead. Only when these two major problems are properly handled can spring be ushered in.
The crux 1: Consumer products can only be played, medical products are the real!
At present, there are many manufacturers of medical wearable devices. Due to the integration of software and hardware, the R&D cycle is long, the capital investment is large, and the product homogeneity is serious. Only diabetes products and applications are in the dozens. Medical wearable devices have the substitution of medical devices or drugs, but lack access and regulation in the medical industry.
First, the reliability of technical indicators is doubtful. Domestic medical devices and drugs have strict approval procedures and comparative evaluation of effects. They need to use raw materials, side effects and double-blind control tests, thus establishing a barrier to entry, effectively curbing unlimited market competition and reducing patient safety hazards. The domestic R&D equipment research and development, there is still no supervision, patients often choose independently, and bear the cost, can not identify the product quality. The lack of government industry regulation restricts the development of the industry. The consistency evaluation of domestic generic drugs is still in the stage of strong push, and it will take time for the regulatory authorities to cover medical wearable devices.
Second, the equipment lacks maintenance and debugging. Medical devices used in hospitals require regular maintenance checks, commissioning and maintenance to ensure reliability and availability. Many medical wearable devices, after being sold as products to patients, focus on consumables revenue, or accumulate patient data, lack the ability to provide similar services, and patients lack the willingness to pay for purchases. Most medical wearable devices are only of the quality of consumer electronics and do not meet industrial control and medical standards. Domestic consumers are generally accustomed to paying for physical products, lacking the habit of paying for services directly, restricting the multiple benefits of wearable device manufacturers.
The third is the unavoidable legal and moral hazard. Based on the above two problems, if the patient simply trusts the wearable device that does not have medical quality, and guides the medication and life according to the data indicators it displays, serious health risks and damages will occur. For example, if a patient chronically trusts a meter with an inaccurate reading, it can lead to irreparable complications. Of course, wearable device manufacturers can use the terms of the format contract to avoid risks, but it is a major obstacle to the development of enterprises and industries.
It is the stone of the mountain. The US FDA has incorporated medical wearable devices and apps into medical device management. It needs to pass the technical and effectiveness test before it can be listed. The threshold is to curb the disorderly competition in the market. Second, it protects patients. Safe and healthy; the third is to confirm the efficacy, providing a basis for the medical insurance department to reimburse it. Therefore, the path of medical wearable devices in the United States gives us a lot of inspiration, points out the development path, and requires the competent authorities of our government to assume corresponding responsibilities.
The crux 2: relying solely on the health data platform, lack of ecological chain, loss of development initiative, medical wearable devices fully realize the connection between people and things, and partially realize the connection between people and things, so that relevant data can be accumulated. Sexuality, liquidity. The cloud computing, big data, Internet of Things, and mobile Internet ("Cloud") of the new generation of information technology are fully embodied in medical wearable devices.
For data storage and applications, most wearable device manufacturers build their own proprietary strategies. At the same time, some platform companies have launched medical application data platforms, user-based, cross-application personal health data collection storage and applications, such as Apple Heath Kit platform (June 2014), Google Google Fit platform (2014 8 Month), Samsung Sami platform (May 2014), Tencent WeChat hardware platform (July 2014), Baidu Dulife intelligent health equipment platform (December 2013) and so on.

The above companies rely on their ecological chain to develop applications such as speech recognition and deep learning, such as Apple Siri, Google Google Now, Microsoft Xiao Bing and Cortana (Xiao Na) and Baidu. With the gradual evolution of its natural language recognition, computer deep learning, cloud computing, and big data processing, it will not only affect the Internet medical applications such as light consultation, clinical consultation, chronic disease management, and follow-up, but also wearable. The implementation of the device produces a subversive change. Therefore, correctly responding to and rationally applying the above-mentioned health data platform and selecting the appropriate platform are the key decisions for the future development of wearable devices.
At the same time, wearable device manufacturers should always prevent the above-mentioned platform companies from launching their own alternative products, and the competition between “pro-son” and “dry son”, such as Apple iWtach and Google Google Glass, will be the same. Some healthy wearable devices are completely replaced. These platform companies not only have the ability to “think and think”, but also aggregate and support the data platform. They also have the strength of “downgrading” and develop killer products.
Medical wearable devices have broad application prospects, but have not yet reached the stage of explosive development in China. The critical point of its outbreak still needs government supervision, platform assistance, enterprise R&D and decision-making to promote it.

Source: China Digital Medical Network, Internet Medical China Association

Sweeteners


Sweeteners refer to Food Additives that can impart sweetness to soft drinks. Sweeteners can be divided into nutritive sweeteners and non-nutritive sweeteners according to their nutritional value; according to their sweetness, they can be divided into low-sweetness sweeteners and high-sweetness sweeteners; according to their source Divided into natural sweeteners and synthetic sweeteners.

Here you can find the related products in Sweeteners, we are professional manufacturer of Sweeteners. We focused on international export product development, production and sales. We have improved quality control processes of Sweeteners to ensure each export qualified product.

Here you can find the related products in Sweeteners, we are professional manufacturer of Sweeteners like D-Mannose, Raffinose, Sucralose, Maltitol, Erythritol, Sorbitol and so on.


D-Mannose, Raffinose, Sucralose, Maltitol, Erythritol, Sorbitol

Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bios.com

Posted on